Ketoconazole is a synthetic imidazole derivative indicated in the treatment of superficial and deep mycoses (1). This paper reports its successful use in the management of a patient with oesophageal candidiasis which had failed to respond to alternative therapies.
Get full access to this article
View all access options for this article.
References
1.
SymoensJMoensMScheygronH. An evaluation of two years of clinical experience with ketoconazole. Rev Infect Dis1980; 2:570–577.
2.
ThienpontDvan CusremJBorgersM. Ketoconazole in experimental candidiasis. First International Symposium in Ketoconazole. Medenin, Columbia, Nov 29–30, 1979. Rev Infect Dis.
3.
LandbergDGraybillRDonovanWLevineHBDrutzDJDiazM. Clinical evaluation of ketoconazole in the treatment of systemic fungal infections. Eleventh International Congress of Chemotherapy & 19th Interscience Conference on Antimicrobial Agents & Chemotherapy. Boston, Massachusetts, Oct. 1–5, 1979.
4.
Van der BeerJWMKeuningJJScheijgrondHWHeykantsJvan CustemJBrugmansJ. The Influence of gastric acidity on the bioavailability of ketoconazole. Correspondence. J Antimicrob Chemother552–554.
5.
TrigerDRSlaterDNGoepelJRUnderwoodJCE. Systemic candidiasis complicating acute hepatic failure in patients treated with cimetidine. Lancet1981; 2:837.
